Factor XI deficiency: A description of 34 cases and literature review

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 5, 2011, Pages 431-435

  Santoro, Rita ^a   Prejanò, Simona ^a   Iannaccaro, Piergiorgio ^a  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

bleeders; bleeding phenotype; factor XI deficiency; nonbleeders

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL ARTICLE; FEMALE; GENETIC ANALYSIS; HUMAN; INHERITANCE; ITALY; MALE; MEDICAL LITERATURE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW;

FACTOR XI DEFICIENCY; FEMALE; HEMORRHAGE; HEMORRHAGIC DISORDERS; HUMANS; ITALY; MALE; PREGNANCY;

EID: 79960698602     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834689e4     Document Type: Review

References (32)

1. Rosenthal RL, Dreskin OH, Rosenthal N. New haemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82:171-174
2. Seligsohn U. Factor XI deficiency. Thromb Haemost 1993; 70:68-71 (Pubitemid 23225453)
3. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds: a clinical and laboratory study. Thromb Haemost 1995; 73:194-202
4. Bolton-Maggs PH. Factor XI deficiency: resolving the enigma? Haematology 2009; ASH Educ Program 97-105
5. Zucker M, Zivelin A, Landau M, Rosenberg N, Seligshon U. Three residues at the interface of factor XI monomers augment covalent dimerization of factor XI. J Thromb Haemost 2009; 7:970-975
6. Samuel D, Cheng H, Riley PW, Canutescu AA, Nagaswami C, Weisel JW, et al. Solution structure of the A4 domain of factor XI sheds light on the mechanism of zymogen activation. Proc Natl Acad Sci U S A 2007; 104:15693-15698 (Pubitemid 350035362)
7. Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest 1997; 99:2323-2327 (Pubitemid 27227707)
8. Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987; 26:7221-7228 (Pubitemid 18002123)
9. Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi Jews. Blood 1978; 51:1223-1228 (Pubitemid 8344664)
10. Goldstein DB, Reich DE, Bradman N, Usher S, Seligsohn U, Peretz H. Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet 1999; 64:1071-1075 (Pubitemid 30463038)
11. Peretz H, Mulai A, Usher S, Zivelin A, Segal A, Weisman Z, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood 1997; 90:2654-2659 (Pubitemid 27413475)
12. Meijers JC, Davie EW, ChungDW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992; 79:1435-1440
13. Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, Seligsohn U. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002; 99:2448-2454 (Pubitemid 34525431)
14. Bolton-Maggs PH, Peretz H, Butler R, Mountford R, Keeney S, Zacharski L, et al. A common ancestral mutation (C128X) occurring in 11 non-Jewish families from the UK with factor XI deficiency. J Thromb Haemost 2004; 2:918-924 (Pubitemid 40185739)
15. Mitchell M, Mountford R, Butler R, Alhaq A, Dai L, Savidge G, Bolton- Maggs PH. Spectrum of factor XI (F11) mutations in the UK population: 116 index cases and 140 mutations. Hum Mutat 2006; 27:829
16. Tomaiuolo M, Favuzzi G, Cappucci F, Pisanelli D, Tiscia GL, Musto P, et al. Factor XI deficiency: two novel mutations in asymptomatic Italian patients. Haemophilia 2010; 16:767-770
17. Saunders RE, O'Connell NM, Lee CA, Perry DJ, Perkins SJ. Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools. Hum Mutat 2005; 26:192-198 (Pubitemid 41254374)
18. Rapaport SI, Schiffman S, Patch MJ, Ware AG. A simple, specific onstage assay for plasma thromboplastin antecedent activity. J Lab Clin Med 1961; 57:771-780
19. Leiba H, Ramot B, Many A. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1965; 11:654-665
20. Bolton-Maggs PHB, Young Wan-Yin B, McCraw AH, Slack J, Kernoff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69:521-528
21. Condie RG. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by preeclampsia. Br J Obstet Gynaecol 1976; 83:636-639
22. Hilgartner MW, Smith CH. Plasma thromboplastin antecedent (factor XI) in the neonate. J Paediatr 1965; 66:747-752
23. Nossel HL, Lanzkowsky P, Levy S, Mibashan RS, Hansen JD. A study of coagulation factor levels in women during labour and in their newborn infants. Thromb Diath Haemorrh 1966; 16:185-197
24. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in patients with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105:314-321 (Pubitemid 28123582)
25. Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325:153-158
26. Tavori S, Brenner B, Tatarsky I. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Thromb Haemost 1990; 63:36-38 (Pubitemid 20057310)
27. Bolton-Maggs PH, Perry DJ, Chalmers EA, Parapia LA, Wilde JT, Williams MD, et al. The rare coagulation disorders: review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10:593-628 (Pubitemid 39317772)
28. Castaman G, Ruggeri M, Rodeghiero F. Clinical usefulness of desmopressin for prevention of surgical bleeding in patients with symptomatic heterozygous factor XI deficiency. Br J Haematol 1996; 94:168-170 (Pubitemid 26232561)
29. Salomon O, Zivelin A, Livnat T, Seligsohn U. Inhibitors to factor XI in patients with severe factor XI deficiency. Semin Hematol 2006; 1 (Suppl 1):S10-S12 (Pubitemid 43150492)
30. Livnat T, Tamarin I, Mor Y, Winckler H, Horowitz Z, Korianski Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost 2009; 102:487-492
31. Bern MM, Sahud M, Zhukov O, Qu K, MitchellW Jr. Treatment of factor XI inhibitor using recombinant activated factor VIIa. Haemophilia 2005; 11:20-25 (Pubitemid 40253763)
32. Schulman S, Nemeth G. An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency. Haemophilia 2006; 12:223-227